Today, Americans pay the highest prescription drug prices in the world while pharmaceutical companies earn record profits.
The majority of Americans — 59% — are worried about affording prescription drugs. One in five say they skipped or rationed a medication in the past year because of the cost.
The system is rigged against patients — and drug companies engineer it to stay that way. Here's how, and what we're doing about it.
59%
of Americans are worried about affording prescription drugs
1 in 5
skipped or rationed a medication in the past year because of the cost
Where We Stand
Every person in the United States should be able to get the prescription drugs they need atprices they can afford.
Our current priorities:
01
Expanding Medicare negotiation
The Medicare Drug Price Negotiation Program is already lowering costs for millions of Americans. Congress should build on that success — not allow Big Pharma to roll it back.
We're fighting to expand the number of expensive drugs eligible for negotiation, shorten the time patients must wait before lower prices take effect, protect the program from industry attacks, and extend the benefits of negotiated prices to more Americans.
02
Increasing Competition To Lower Prices
Competition is one of the most effective ways to lower prescription drug prices. When generics and biosimilars reach the market, prices fall—but too often, drug companies manipulate the patent and regulatory systems to delay lower-cost alternatives.
We support reforms that curb patent abuse, remove unnecessary regulatory barriers, and help lower-cost generic and biosimilar medicines reach patients sooner. We're also working to reform pharmacy benefit manager (PBM) practices that undermine competition and prevent savings from reaching patients.
03
Restoring Balance Throughout the System
Patients deserve a prescription drug system that works for them—not just the companies that profit from it. Drug companies have too much power to set prices without regard for what patients can afford, including launching new medicines at exorbitant prices that put treatments out of reach from day one.
We support reforms that rein in excessive launch prices, increase transparency, and hold companies across the prescription drug supply chain accountable. We need a system that rewards meaningful innovation while ensuring patients can afford and access the medicines they need.
The Playbook
Our legislative agenda
Congress has the power to lower prescription drug prices—or make it harder for patients to afford the medicines they need. Our legislative agenda highlights the reforms we're advancing and the harmful proposals we're working to stop.
01
Solutions we support
We focus on the biggest levers in the system — with the greatest potential to lower costs for the most patients.
